Rchr
J-GLOBAL ID：200901060002775582   Update date: Nov. 19, 2024

Kiyota Naomi

キヨタ ナオミ | Kiyota Naomi
Affiliation and department：
Kobe University University Hospital Cancer Center

About Kobe University University Hospital Cancer Center


Research field  (1)： Hematology and oncology
Research theme for competitive and other funds  (16)：
  • 2023 - 2027 B細胞を軸とした免疫チェックポイント阻害の有害事象の包括的機序解明と効果の推定
  • 2023 - 2026 唾液腺癌における免疫微小環境の特徴と免疫関連バイオマーカーの探索
  • 2020 - 2023 Genetic alterations and expressions of immune check point molecules in sinonasal neuroendocrine carcinoma
  • 2019 - 2023 Clinical research in the development of patient reported outcome measures for cancer patients
  • 2017 - 2020 Genetic alterations and expressions of immune check point molecules in salivary gland cancer
Show all
Papers (293)：
  • Susanne Singer, Eva Hammerlid, Iwona M Tomaszewska, Cecilie D Amdal, Bente B Herlofson, Marcos Santos, Joaquim Castro Silva, Hisham Mehanna, Amy Fullerton, Teresa Young, et al. The european organisation for research and treatment of cancer head and neck cancer module (EORTC QLQ-HN43): Estimates for minimal important difference and minimal important change. European journal of cancer (Oxford, England : 1990). 2024. 212. 115062-115062
  • Yoshiaki Nagatani, Naomi Kiyota, Yoshinori Imamura, Taiji Koyama, Yohei Funakoshi, Masato Komatsu, Tomoo Itoh, Masanori Teshima, Ken-Ichi Nibu, Kazuko Sakai, et al. Different characteristics of the tumor immune microenvironment among subtypes of salivary gland cancer. Asia-Pacific journal of clinical oncology. 2024
  • Yoshinori Imamura, Naomi Kiyota, Makoto Tahara, Takeshi Kodaira, Ryuichi Hayashi, Hiroshi Nishino, Yukinori Asada, Hiroki Mitani, Shigemichi Iwae, Naoki Nishio, et al. Effect of acute kidney injury and overall survival in patients with postoperative head and neck cancer who received chemoradiotherapy with cisplatin: A supplementary analysis of the phase II/III trial of JCOG1008. Cancer medicine. 2024. 13. 18. e70235
  • Kazuki Yokoyama, Koichiro Wasano, Keita Sasaki, Ryunosuke Machida, Mitsuhiko Nakahira, Koji Kitamura, Tomofumi Sakagami, Naohiro Takeshita, Akira Ohkoshi, Motoyuki Suzuki, et al. Frequency of use and cost in Japan of first-line palliative chemotherapies for recurrent or metastatic squamous cell carcinoma of the head and neck. Japanese Journal of Clinical Oncology. 2024
  • Hidetoshi Shimizu, Takeshi Kodaira, Naomi Kiyota, Ryuichi Hayashi, Hiroshi Nishino, Yukinori Asada, Hiroki Mitani, Yuuji Hirayama, Yusuke Onozawa, Naoki Nishio, et al. Incidence and risk factors associated with the development of hypothyroidism after postoperative chemoradiotherapy for head and neck cancer patients with high-risk features: Supplementary analysis of JCOG1008. Oral oncology. 2024. 157. 106976-106976
ｍore...
MISC (189)：
  • 今村善宣, 能勢拓, 大幡真也, 乙井一典, 乙井一典, 森健太, 辻高寛, 宮田吉晴, 金原史朗, 長谷善明, et al. 進行・再発・転移の固形腫瘍における血栓塞栓症と出血リスク:PROVE-emboli試験post-hoc解析. 日本血栓止血学会誌. 2024. 35. 2
  • 花房 宏昭, 田中 敬子, 濱 真奈美, 金原 史朗, 益子 尚久, 坊 亮輔, 國久 智成, 粟野 宏之, 清田 尚臣, 久保 亮治, et al. がんゲノムプロファイル検査でRAD51Dが検出され、事前のリスク低減卵管卵巣摘出術についての情報交換が有用であった症例. 日本遺伝カウンセリング学会誌. 2023. 44. 2. 139-139
  • 今村善宣, 能勢拓, 宮田吉晴, 小山泰司, 長谷善明, 金原史朗, 船越洋平, 清田尚臣, 藥師神公和, 南博信. がん関連静脈血栓塞栓症に対するアピキサバン療法の出血リスク予測:多施設共同第2相臨床試験副次的解析. 日本内科学会雑誌. 2023. 112
  • 今村善宣, 能勢拓, 大幡真也, 森健太, 乙井一典, 宮田吉晴, 金原史朗, 長谷善明, 小山泰司, 船越洋平, et al. 進行・再発・転移の未治療固形がん患者における静脈血栓塞栓症の前向き観察研究の統合解析. 日本血栓止血学会誌. 2023. 34. 2
  • 平川結梨, 藥師神公和, 松本咲耶, 坂井里奈, 倉田啓史, 今村善宜, 北尾章人, 船越洋平, 田中秀和, 清田尚臣, et al. 小児がん経験者の移行期医療の現状およびがん治療歴と心機能に関する解析. 日本腫瘍循環器学会学術集会抄録集(Web). 2023. 6th
ｍore...
Books (19)：
  • 頭頸部がん薬物療法ハンドブック
    中外医学社 2021 ISBN:9784498022881
  • 新臨床腫瘍学 : がん薬物療法専門医のために
    南江堂 2021 ISBN:9784524227396
  • 頭頸部がん薬物療法ガイダンス / 頭頸部がん薬物療法ガイダンス
    金原出版株式会社 2018
  • 新臨床腫瘍学 / 41 内分泌がん
    南江堂 2018
  • 頭頸部癌診療ガイドライン2018年版 / 頭頸部癌診療ガイドライン2018年版
    金原出版株式会社 2017
ｍore...
Lectures and oral presentations  (233)：
  • シスプラチン併用化学放射線療法の現状とこれから:術後シスプラチン併用化学放射線療法
    (第47回日本頭頸部癌学会 2023)
  • Darolutamide for patients with androgen receptor positive salivary gland cancers (DISCOVARY): The results of phase 2 study of darolutamide monotherapy
    (ASCO2023 2023)
  • A phase II trial of nivolumab for patients with platinum-refractory recurrent or metastatic salivary gland cancer.
    (ASCO2023 2023)
  • A risk prediction model for cisplatin-induced acute kidney injury in head and neck cancer patients who receive chemoradiotherapy: A supplement analysis of a phase II/III trial of JCOG1008
    (ASCO2023 2023)
  • Impact of acute kidney injury on overall survival in postoperative patients with head and neck cancer who received chemoradiotherapy with cisplatin: A supplementary analysis of a phase II/III trial of JCOG1008
    (ASCO2023 2023)
ｍore...
Education (1)：
  • - 1999 Kobe University School of Medicine Faculty of Medicine
Professional career (2)：
  • 学士(医学) (神戸大学)
  • 博士(医学) (神戸大学)
Awards (2)：
  • 2020/12 - JCOG Shimoyama Masanori Award
  • 2014/12 - JCOGデータセンター Best Study Coordinator賞 JCOG研究者
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM